Eikon Therapeutics, Inc.
EIKN
$15.05
$0.221.48%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Net Income | -64.92M | ||||
| Total Depreciation and Amortization | 6.22M | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 1.74M | ||||
| Change in Net Operating Assets | 33.23M | ||||
| Cash from Operations | -23.74M | ||||
| Capital Expenditure | -39.52M | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | 47.67M | ||||
| Cash from Investing | 8.15M | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 95.00K | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 95.00K | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -15.49M | ||||